Cite
HARVARD Citation
Gayko, U. et al. (2015). Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies. Annals of the New York Academy of Sciences. 1358 (1), pp. 82-94. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gayko, U. et al. (2015). Development of the Bruton's tyrosine kinase inhibitor ibrutinib for B cell malignancies. Annals of the New York Academy of Sciences. 1358 (1), pp. 82-94. [Online].